TGFB1 and metabolic dysfunction-associated steatohepatitis: i.e., TGFβ represses the expression of nutrient receptors, glycolytic capacity and OXPHOS overall reducing NK cell cytotoxicity, supporting that inhibiting TGFβ could restore NK cell function during NAFLD/NASH (63, 77).